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Twenty four women were studied in order to examine the effect 
that discontinued iron supplementation has on the hematological 
values of serum ferritin, serum iron and hemoglobin. 
Initially, 111 female volunteers were screened for iron 
deficiency by blood analysis (serum ferritin below 20 jug/L and/or 
hemoglobin below 120 g/L). On the basis of ferritin and hemoglobin 
measurements, 44 women (39.6%) qualified as iron deficient. Twenty 
four of the selected women completed the 24 week study. Mean age 
was 27.6 ± 7.5 years (range 18 to 40 years). Each of the subjects 
received the treatment of oral iron supplements (320 mg ferrous 
sulfate = 100 mg elemental iron taken as SLOW-Fe twice a day) for 
12 weeks. Supplementation was then discontinued for an additional 
12 weeks. Measurements of serum ferritin, serum iron and 
hemoglobin were taken at 0, 6, 12, 18 and 24 weeks of the study. 
Statistical analysis using analysis of variance (ANOVA) 
indicated significant changes (p<.05) in serum ferritin and serum 
iron values. No significant (p<.05) change was found in hemoglobin 
values over the course of the study. Student-Newman-Keuls post hoc 
test was used to identify specific mean differences when a 
significant F ratio was observed. Serum ferritin values 
were significantly (p<.05) increased following 6 (11.5 ± 5.3 to 
26.4 ±14.3 Atg/L) and 12 (11.5 ± 5.3 to 30.6 ± 14.9 /txg/L) weeks of 
oral iron supplementation. Twelve weeks of discontinued 
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supplementation did not significantly (p<.05) alter serum ferritin 
values as noted by mean values of 29.0 ± 15.0 /xg/L and 28.2 ± 17.1 
Aig/L for weeks 18 and 24, respectively. Serum iron values were 
significantly (p<.05) increased (15.9 ± 6.7 to 25.4 ± 15.6 ^mol/L) 
after 6 weeks of oral iron supplementation. Serum iron values at 
12, 18 and 24 weeks of the study were not significantly (p<. 05) 
different from the values at week 0 and week 6. 
It can be concluded that oral iron supplementation (32 0 mg 
ferrous sulfate = 100 mg elemental iron taken as Slow Fe twice a 
day for 12 weeks) was successful in raising serum ferritin values 
(from 11.5 ± 5.3 to 30.6 ± 14.9 /xg/L) in iron deficient women. 
Within the limitations of this study, 12 weeks of discontinued oral 
iron supplementation does not pose a threat to the iron status of 
iron repleted women. 
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Iron deficiency affects approximately 10 to 30% of the world 
population (Beck, 1985). In Western countries iron deficiency is 
the most common nutritional deficiency (Beck, 1985). It is more 
commonly seen in women than men, especially women of child- 
bearing age. Women tend to be at an increased risk of developing 
iron deficiency due to the loss of iron through menstruation and 
pregnancy (deGruchy, 1970). Women also tend to have low daily 
iron intakes which may add to the problem. In a 1973 survey by 
Nutrition Canada, 76% of Canadian women had iron intakes below 
the recommended levels for the general population (Health & 
Welfare Canada, 1975). 
To improve the iron status of iron deficienct women a 
variety of supplementation programmes have been developed 
(Haymes, 1980). Whether it be through oral or parenteral 
administration many women use some type of a supplementation 
programme on a regular basis. Within the United States it has 
been estimated that 37% of the general adult population use 
nutrient supplements, and approximately 58% of these individuals 
use a mulitivitamin containing iron and/or other minerals (The 
Gallop Organization, 1982). 
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The effect of oral iron supplementation on the iron status 
(i.e., serum ferritin, serum iron and hemoglobin) of women has 
been well documented. Many studies have shown an improvement in 
the iron status of women taking iron supplements (Plowman & 
McSwegin, 1981; Schoene, Escourrov, Robertson, Nilson, Parsons, & 
Smith, 1983; Charoenlarp et al., 1988; Newhouse, Clement, 
Taunton, & McKenzie, 1989) and today iron supplementation is well 
recognized as a therapeutic remedy for iron deficiency. However, 
such studies have not addressed the possibility that the iron 
stores may have diminished shortly after the discontinuation of 
the supplementation programme. Within the clinical setting iron 
supplementation, in many cases, is continued only until iron 
stores have been replenished. But what happens to the iron 
stores once the supplementation programme has been discontinued? 
A study by Hercberg, Galan, Soustre, Dop, Devanlay, and 
Dupin (1985) examined the iron status of 54 women after 30 days 
of iron supplementation (105 mg/day of elemental iron) and 30 
days of subsequent discontinuation. Mean ferritin levels were 
significantly increased with supplementation, while subsequent 
discontinuation significantly (p<.05) decreased ferritin levels 
from 46.4 ± 30.3 to 40.6 ± 23.4 /ig/L. Although Hercberg et al.'s 
(1985) study did not focus specifically on the effect of 
discontinued iron supplementation it does suggest that some women 
may be at a risk of developing iron deficiency soon after a 
successful supplementation programme. 
3 
Purpose of study 
This study was designed for the primary purpose of examining 
the effects of discontinuing iron supplementation on the 
hematological values of serum ferritin, serum iron and hemoglobin 
in a group of iron replete women who were previously iron 
deficient. The study was also designed to; (a) establish the 
prevalency of iron deficiency in a group of women and, (b) to 
examine the effects of iron supplementation on the hematological 
values of serum ferritin, serum iron and hemoglobin in a group of 
iron deficient women. 
Research Hypothesis 
Testing of the following null hypotheses was proposed to 
meet the purpose of the study. 
1. There are no differences in pre-discontinued and post- 
discontinued values of serum ferritin, serum iron and hemoglobin 
following the discontinuation of iron supplements. 
2. There are no differences in pre-supplement and post-supplement 
values of serum ferritin, serum iron and hemoglobin following 
iron supplementation. 
4 
Significance of Study 
Possible outcomes of the study included: (a) iron status of 
the group of women remained elevated for the entire 12 weeks 
following the discontinuation of iron supplements or, (b) the 
iron status of the group of women returned to an iron deficient 
state within the 12 weeks following the discontinuation of iron 
supplements. 
The first outcome would suggest that the need for 
supplementing iron deficient patients for prolonged periods of 
time is unnecessary. This would support the current clinical 
practice of prescribing oral iron supplements for 2 to 3 months. 
Taking this a step further, some patients may find that by taking 
oral iron supplements for shorter periods of time or on a less 
frequent basis improves their iron status to the same degree as 
with a daily extended supplementation programme. A recent study 
by Wright and Southon (1990) suggests that less frequent iron 
supplementation, such as every 2nd or 3rd day, may be equally as 
beneficial to iron deficient subjects as routine daily 
supplementation. Such a regimen may minimize unpleasant side- 
effects of oral iron therapy, decrease the risk of adverse 
effects of iron on the absorption of other essential minerals and 
substantially cut the cost of supplementation programmes. 
The second outcome may imply that iron supplementation is 
somewhat futile unless administered on an on-going basis or for 
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longer periods of time. Either way, this is a project that will 
have an impact on the well being of a significant number of 
females in the population. 
Limitations 
1) Training, diet, menstrual blood loss and other physical 
factors which may have affected the testing were beyond the 
control of the investigator. 
2) Subjects rate of iron depletion were slightly accelerated by 
the withdrawl of blood samples. 
3) Exclusion criteria employed cutoff points that arbitrarily 
established levels of normality or deficiency. This is 
particularily important considering the normal variability of 
each iron variable. 
4) The subjects willingness to follow instructions concerning 
personal nutritional habits and activities. 
5) An alpha level of .05 was established as the level of 
significance for statistical tests. 
Delimitations 
1) This study was delimited to females, age 18 to 40, with iron 
deficiency who resided in the vicinity of Thunder Bay, 
Ontario. 
2) The only blood parameters that were measured included serum 
ferritin, serum iron and hemoglobin. 
3) Due to ethical concerns, compounding blood loss effects and 
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money constraints, blood analysis occurred only at 6 week 
intervals during the 24 week study period. Significant 
changes in iron status that could possibly occur over a 
shorter time span were not investigated. 
Definitions 
Iron Status; 
Serum Ferritin: a sensitive index of the earliest stage of 
iron deficiency-depletion of body iron reserves (Valberg, 1980). 
It is estimated that one ug/L of serum ferritin is equivalent to 
8 mg of storage iron (Walters, Miller & Worwood, 1973). Levels 
below 20 ug/L are associated with absent bone marrow iron 
(Pakarinen, 1980). Levels up to 64 ug/L may still represent an 
iron deficient state (Heinrich, Bruggemann, Gabbe, & Glaser, 
1977) . 
Serum Iron: (also called plasma iron and total iron); useful 
in the clinical evaluation of iron deficient erythropoeisis. 
Exhaustion of the iron stores affects the supply of iron to the 
plasma pool and hence to the erythroid bone marrow (Bothwell, 
Charlton, Cook & Finch, 1979). 
Hemoglobin: an iron containing conjugated protein found in 
red blood cells and capable of transporting oxygen and carbon 
dioxide to and from the working tissues. 
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Iron Deficiency; 
A state which develops if the loss of iron is greater than 
the amount obtained (Pakarinen, 1980). Iron deficiency is 
commonly divided into three stages: (a) prelatent, (b) latent, 
and (c) manifest (Clement & Sawchuk, 1984). 
a) Prelatent iron deficiency: the earliest stage of iron 
deficiency characterized only by a decrease in storage iron 
(and decreased serum ferritin) and increased intestinal 
absorption (Strauzneberg, Kassner, Bohm & Schneider, 1981). 
b) Latent iron deficiency: in addition to the indices of 
prelatent iron deficiency, the level of total serum iron is 
decreased (Strauzenberg et al., 1981). The criterion for 
prelatent/latent iron deficiency in this study is serum 
ferritin levels below 20 /ug/L. Levels below this are 
associated with absent bone marrow iron (Pakarinen, 1983; 
cited in Clement & Sawchuk, 1984). 
c) Iron deficiency anemia: refers to an advanced stage of iron 
deficiency characterized by a drop in hemoglobin levels 
(Clement & Sawchuk, 1984). In this study the criterion will 
be levels below 120 g/L (Williamson, 1981). 
CHAPTER 2 
REVIEW OP LITERATURE 
Introduction 
Due to the lack of literature pertaining to the 
discontinuation of iron supplementation, the general theory of 
the metabolism, requirements, status, and supplementation of iron 
will be discussed. 
Iron metabolism 
Iron, a metallic element, is found in two forms; ferrous, a 
divalent form (Fe**) of iron, and ferric, a trivalent form (Fe"^**) 
of iron. During intestinal absorption iron must be in an ionic 
state and almost exclusively in the ferrous form (deGruchy, 
1970). Most foods, however, contain iron in its ferric form 
bound to protein (Sonnenwirth & Jarett, 1980). Therefore prior 
to absorption iron must be split from the protein and reduced to 
its ferrous form within the stomach (Sonnenwirth & Jarett, 1980). 
Within the stomach acids such as hydrochloric and organic acids, 
release ferric iron from protein (deGruchy, 1970). The released 
free ferric ions are then reduced to the ferrous form at an acid 
pH by reducing agents in the food such as ascorbic acid 
(deGruchy, 1970). These free ferrous ions are mainly absorbed in 
the duodenum and upper small intestine, though some absorption 
occurs in the stomach, ileum, and colon (Winick, 1981). The 
absorptive mechanism which is regulated by the intestinal mucosal 
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cells, occurs in two phases. First, evidence suggests that a 
protein called mucosal transferrin binds with iron in the lumen 
of the gut and transports it across the border of the intestinal 
mucosa (Finch & Hueber, 1982). Second, iron within the 
intestinal mucosal cells may be bound either to apotransferrin 
and absorbed into the bloodstream as transferrin, or to 
apoferritin and deposited as ferritin within the mucosal cell 
itself (Winick, 1981). 
Iron absorption 
According to Winick (1981) the two most important internal 
factors regulating the amount of iron absorbed are the size of 
internal iron stores and the rate of erythropoiesis. Experiments 
have shown that a decrease of iron stores increases absorption 
while an increase in iron stores decreases absorption (deGruchy, 
1970). For example, in humans with iron deficiency the amount of 
food iron absorbed is increased from the usual 5 to 10 per cent 
to between 10 and 20 per cent (deGruchy, 1970). Other 
experiments have shown the effect of the rate of erythropoiesis 
on iron absorption. For example, the stimulation of 
erythropoiesis by the induction of hemolysis or by hemorrhage 
increases iron absorption while transfusion-induced polycythemia 
reduces the absorption of iron (deGruchy, 1970). 
10 
However, it is not understood how the bone marrow or iron 
stores inform the small intestine of their needs, or how the 
intestinal wall regulates the degree of absorption. Originally, 
it was thought that the degree of saturation of the iron acceptor 
protein, apoferritin, in the mucosal cells played the major role 
in controlling absorption of iron (deGruchy, 1970). This theory, 
known as the mucosal block theory, postulated that when all the 
apoferritin in the mucosal cells was converted to ferritin 
absorption of iron ceased (deGruchy, 1970). Although this theory 
has since been refuted it does appear that the mucosal cells do 
play a controlling role in determining the amount of iron 
absorbed. Iron transfer across the mucosal cell is part of an 
active metabolic process. In this process a proportion of the 
iron taken up by the mucosal cells is delivered to the 
transferrin of the plasma while the remainder is deposited as 
ferritin in the mucosal cells (deGruchy, 1970). It appears that 
both transferrin and ferritin may play an important role in 
determining the amount of iron absorbed (Finch & Hueber, 1982). 
Other factors which are claimed to affect iron absorption 
but appear to be of much less importance include the amount of 
iron in diet, form of iron in diet (bioavailability), pancreatic 




In healthy individuals, body iron is repeatedly reutilized; 
hence, daily absorption and loss of iron tends to be small (Beck, 
1985}. However, despite the minuteness of daily iron turnover, 
iron balance within the body is important. Generally, iron 
balance is maintained by physiological adjustment of the 
absorption mechanism so that the amount of iron crossing the 
small intestinal epithelial barrier is related to the internal 
iron status, type and amount of dietary iron, and the rate of 
erythropoiesis (Parr, Bachman, & Moss, 1984). 
Typically, Western diets contain about 7 mg of iron per 1000 
calories (U.S. Deptartment of Health, Education, and Welfare, 
1972). According to Hallberg (1984) only a small portion of the 
iron in food is absorbed, and this amount varies greatly, 
depending on the composition of the diet. A normal individual 
absorbs about 4-10% of the total iron ingested (Beck, 1985). 
Such percentages vary depending on the type of food ingested. 
For example, eggs, liver and leafy vegetables have low absorption 
values, whereas muscle, fish and soybeans have higher absorption 
values (Beck, 1985) . 
Dietary iron, which enters a common pool within the 
intestinal lumen, exists as either heme iron or non-heme (ionic) 
iron. Within foods each of these irons are bound to other 
constituents that either interfere with or promote iron 
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absorption. Heme iron is bound to porphyrin in hemoglobin and 
myoglobin and is not affected by other dietary components 
allowing up to 35% of the iron to be absorbed by iron-deficient 
subjects (Winick, 1981). For non-heme, or ionic, iron the case 
is much different. Ionic iron is present in foods as part of a 
ferric hydroxide complex. Various components of a individuals 
diet such as, phytates and phosphates, will combine with ionic 
iron to form insoluble salts making the iron less available for 
absorption. Therefore, certain good sources of iron, such as 
corn (high in phytates) and eggs (high in phosphates), do not 
supply the amount of usable iron one would think. For example, 
the absorption of iron from grains and vegetables alone would be 
less than 5% (Finch & Hueber, 1982). In contrast, foods 
containing reducing subtances like meat and ascorbic acid will 
combine with ionic iron to favour absorption (Winick, 1981). 
Body iron 
Total body iron is estimated to be between 2 and 6 gm or an 
average of 35 mg per kg of body weight (Parr et al., 1984). Of 
this total, 60% to 70% is classified as essential or functional 
iron, and is incorporated into hemoglobin, myoglobin, and certain 
respiratory enzymes (Clement & Sawchuk, 1984). The remaining 30% 
to 40% of the total body iron is classified as storage iron and 
is reserve for any iron imbalances (Clement & Sawchuk, 1984). It 
is estimated that, in females, total body iron is distributed as 
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follows: 60% to 70% (2.5 g) in hemoglobin; 10% to 12% (0.3 g) in 
myoglobin and enzymes; and 29% (0.3 g) as ferritin and 
hemosiderin, stored in the liver, spleen, and bone marrow 
(Winick, 1981). 
Of the storage iron, 65% is in the form of ferritin and the 
remaining 35% as hemosiderin (Sonnenwirth & Jarett, 1980). 
Studies have indicated that in healthy individuals serum ferritin 
measurements provide an accurate estimation of body iron stores 
(Jacobs, Millen, Worwood, Beamish, & Wardrop, 1972; Lipschitz, 
Cook, & Finch, 1974; Walters et al., 1973). It is estimated that 
1 Mg/L of ferritin is equivalent to 8 mg of storage iron (Walters 
et al., 1973). Certain conditions such as infection, 
inflammation, or malignancy are known to elevate serum ferritin 
measurements (O'Toole, Iwane, Douglas, Applegate & Hiller, 1989). 
Other studies have shown that serum ferritin values may be 
elevated following strenuous training bouts (Dickson, Wilkinson, 
& Noakes, 1982; Lampe, Slavin, & Apple, 1986; Taylor et al., 
1987). However, according to Pakarinen (1980) the only condition 
in which serum ferritin concentration is decreased is iron 
deficiency. 
Hemosiderin, which cannot be readily mobilized, is the main 
storage form of iron during periods of iron overload (Sonnenwirth 
& Jarett, 1980). Therefore, hemosiderin deposits within the 
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liver and bone marrow allow an estimate of the degree of iron 
overload (Sonnenwirth & Jarett, 1980). 
Iron excretion 
Normally, 0.5 to 1 mg of iron is lost daily (Jacobs, 1985). 
The sources of such iron loss include the urine (0.1 mg/day), 
feces (shed cells and microscopic amounts of blood^ 0.6 mg/day), 
and shed cutaneous cells and perspiration (0.1 mg/day) 
(Sonnenwirth & Jarett, 1980). In addition, females lose a 
significant yet variable loss of iron through menstrual blood 
loss. Estimates range from 8 mg to 38 mg per menstrual period 
(Jacobs, 1985; Parr et al., 1984). Therefore, menstrual blood 
loss can account for a daily iron loss of 0.7 to 2 mg/day (Beck, 
1985). Estrogen containing oral contraceptives reduce menstrual 
blood loss by about one-half, while intra-uterine devices 
increase losses (Finch, 1980). 
Iron requirements 
In a balanced situation iron requirements are largely 
determined by the amount lost from the body (Jacobs, 1985). A 
female of menstrual age requires approximately 1 mg to 2 mg of 
iron per day, while during pregnancy or lactation this increases 
to between 2 mg and 4 mg of iron per day (Beck, 1985). However, 
since only a fraction of the iron present in food is absorbed it 
is necessary to provide larger amounts of iron in the diet to be 
certain that 1 mg to 4 mg will be absorbed. The Canadian 
recommended intake of iron is 14 mg/day (Health and Welfare 
Canada, 1983). 
Diagnostic methods 
Measurement of body iron stores is the most reliable method 
of diagnosing iron deficiency (Worwood, 1977). There are only a 
few points at which the metabolic pathways of iron can be 
sampled, these include the blood, bone marrow, liver or urine. 
Hematological examinations are the most common diagnostic method 
used in the indication of iron deficiency (Pakarinen, 1980). The 
parameters of blood which tend to be the most useful in the 
diagnosis of iron deficiency are serum ferritin, serum iron, 
hemoglobin, % transferrin saturation, and unsaturated iron 
binding capacity. 
Serum ferritin which is derived from intracellular 
non-erythroid iron storage compartments is generally recognized 
as a reliable indicator of body iron stores (Jacobs et al., 1972; 
Cook, Lipschitz, Miles, & Finch, 1974; Lipschitz et al., 1974; 
Siimes, Addiego, & Dallman, 1974). In most normal adults serum 
ferritin concentrations lie within the range 15-300 )ug/L, but 
concentrations are related to both age and gender (Jacobs, 1985). 
Generally men have higher serum ferritin concentrations than 
women, however in older individuals there may be very little 
gender difference (Jacobs, 1985). There may be some day-to-day 
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individual variation in serum ferritin concentrations but such 
variation is generally no greater than that which may arise from 
methodological variation (Dawkins, Cavill, Ricketts, & Worwood, 
1979) . 
No condition except iron deficiency has been reported to 
produce low serum ferritin concentrations (Pakarinen, 1980; 
Valberg, 1980). The concentration which marks the lower limit of 
normal is hard to define yet many researchers use 15 ^g/lj as a 
diagnostic indicator of iron deficiency (Jacobs et al.,1972; 
Lipschitz et al., 1974). At the upper end of the serum ferritin 
spectrum factors other than iron storage may affect serum 
ferritin values (Cavill, 1982). Conditions such as tissue 
necrosis, pancreatic, lung, or liver tumours, acute infection or 
inflammation, and/or certain anemias which create a shift of iron 
from erythroid cells to reticuloendothelial stores may account 
for high levels of serum ferritin (Cavill, 1982). If iron 
deficiency is associated with such pathological conditions serum 
ferritin concentrations may be greater than 15 /xg/L (Jacobs, 
1985). 
Measurements of serum iron are a reflection of the amount of 
iron in transit within the body at a particular moment in time 
(Sonnenwirth & Jarett, 1980). Serum iron levels are a result of 
such factors as hemoglobin destruction, iron absorption and the 
release of iron from iron stores (Sonnenwirth & Jarett, 1980). 
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Serum iron normally ranges from 10 to 25 jumol/L for women 
(Statland, Winkel, & Bokelund, 1976). Concentrations below 10 
#imol/L are generally considered to be indicative of iron 
deficiency (Statland et al., 1976). However, the diagnostic 
basis of the serum iron concentration in predicting iron 
deficiency is limited. First, serum iron concentrations tend to 
have poor stability. Zilva and Patson (1966) have shown that 
serum iron is highest in the morning and decreases 30% to 50% by 
evening. A study by Statland et al. (1976) suggests that 
day-to-day variation in serum iron concentration may be 
considerable. In fact, some of the day-to-day variations noted 
in the study were such that on one day the serum iron 
concentration fell to a level associated with iron deficiency and 
on the next day rose to a level equated with iron overload. 
Second, a low serum iron concentration may be associated with a 
number of factors, only one of which is true iron deficiency. 
Acute infection, inflammation or minor injuries have been 
associated with a fall in the serum iron concentration 
(Cavill, 1982). Both chronic and malignant diseases, such as 
rheumatoid arthritis and Hodgkin's disease, are also associated 
with low serum iron concentrations (Cavill, 1982). Women tend to 
have lower serum iron concentrations than do men (Zilva & Patson, 
1966) and menstruation in women may produce a fall in serum iron 
concentrations (Mardell & Zilva, 1967). On the other hand oral 
contraceptives are known to increase serum iron levels in women 
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(Burton, 1967). Therefore, it appears that results from serum 
iron measurements may be diagnostically misleading. 
The largest and most readily assessed iron store is that in 
the hemoglobin of circulating red blood cells (Cavill, 1982). 
Since erythropoiesis is generally the dominant route for plasma 
iron turnover, red blood cell synthesis will be maintained until 
the supply of iron from body iron stores is exhausted. 
Therefore, a fall in hemoglobin concentration tends to be a 
reliable sign of storage iron depletion (Cavill, 1982) . However, 
it should be noted that hemoglobin synthesis can be affected by 
other factors although iron supply tends to be the most common 
(Cavill, 1982). For example in patients suffering from any 
anemia which is not caused by blood loss iron is transfered from 
the red cell compartments to the reticuloendothelial stores 
resulting in a low hemoglobin concentration (Jacobs, 1985) . A 
diurnal variation in hemoglobin concentration has also been 
reported by several authors (McCarthy & Van Slyke, 1939; Biggs & 
Allington, 1951; Stengle & Schade, 1957). As well, strenuous 
exercise has been shown to increase the concentration of 
hemoglobin due to a shift of fluid from the plasma to the 




Iron deficiency is a symptomatic state, which is always 
secondary to an underlying pathogenesis. Such underlying causes 
may be an increased demand of the body for iron, loss of blood by 
hemorrhage, and/or inadequate iron intake (deGruchy, 1970). When 
a negative iron balance occurs iron is mobilized from the tissue 
stores to supply iron for the formation of hemoglobin. The 
depletion of iron from tissue stores occurs in variable stages 
within the body. For this reason, iron deficiency exists in 
three stages, each of increasing severity but not necessarily 
independent of each other. 
The depletion of iron stores in the liver, spleen, and bone 
marrow marks the first stage in the development of iron 
deficiency. This iron depletion stage, also referred to as 
prelatent iron deficiency, is characterized by a decrease in 
storage iron and increased intestinal absorption (Strauzenberg, 
Kassner, Bohm & Schneider, 1981). Prelatent iron deficiency can 
be detected by measuring serum ferritin levels which are 
considered to be proportional to the size of body iron stores 
(Jacobs et al., 1972). Serum ferritin levels below 20 /ig/L of 
blood are considered to be indicative of prelatent iron 
deficiency. Normal values of serum ferritin range from 25 to 59 
/itg/L of blood for women (Parr et al., 1984). 
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Once iron stores are depleted, serum ferritin levels do not 
reflect more advanced degrees of iron depletion. The second 
stage of iron deficiency termed iron deficiency erythropoiesis, 
or latent iron deficiency, is detected by a decrease in serum 
iron levels (below 11 /imol/L), a decrease in transferrin 
saturation (less than 20% saturation), and/or an increase in 
total iron-binding capacity (greater than 400 g/L) (Parr et al., 
1984) . 
It is only when tissue stores are exhausted that the supply 
of iron to the marrow for hemoglobin synthesis becomes 
inadequate, and iron deficiency anemia occurs (deGruchy, 1970). 
Therefore, hemoglobin concentrations serve as an appropriate 
indicator of this late stage. This stage of iron deficiency is 
generally termed manifest iron deficiency or iron deficiency 
anemia and is marked by hemoglobin concentrations below 120 g/L. 
Normal hemoglobin concentrations for women are between 120 and 
160 g/L. 
Iron supplementation 
Iron may be administered by two methods: (a) by oral 
ingestion, or (b) by parenteral injection, either intramuscular 
or intravenous (deGruchy, 1970). The majority of patients tend 
to respond satisfactorily to the cheaper and safer oral iron 
therapy. However, the more expensive parenteral iron, which may 
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be accompanied by severe side effects, is a very useful form of 
treatment in a small number of cases (deGruchy, 1970). 
The success of iron supplementation may be measured in two 
ways: (a) Was there a significant improvement in iron status?, 
and (b) were there any negative side effects? (Newhouse, 1989). 
A potential side effect of oral iron therapy is the interference 
iron may play on other trace minerals, namely, copper and zinc 
(Newhouse, 1989). Other side effects such as nausea, 
constipation and abdominal pain have also been reported to affect 
a small percentage of the population (Newhouse, 1989). 
Oral iron supplementation has been used in an attempt to 
reverse iron deficiency within the female population. Most of 
the early studies, however, failed to show significant group 
improvement following iron supplementation (Cooter & Mowbray, 
1978; Pate, Maguire, & Van Wyk, 1979; Weswig & Winkler, 1974). 
Weswig and Winkler (1974) gave one half of the Oregon State 
University men's varsity swimming team 325 mg of ferrous sulfate 
(65 mg of elemental iron) 6 times a week for 5 months. In 
addition, each individual received a multivitamin supplement 
which included Vitamin C. Neither hemoglobin, blood iron, nor 
plasma iron changed significantly over the treatment period. 
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Cooter and Mowbray (1978) investigated the effects of iron 
supplementation on serum iron, total iron binding capacity, 
hemoglobin and percent hemoglobin saturation with iron. After 
administering 18 mg of ferrous sulfate 5 times a week for 4 
months to 5 female college basketball players no significant 
changes were observed in any of the experimental variables. 
In another similar study Pate et al. (1979) studied the 
effects of iron supplementation in 26 female athletes from the 
University of South Carolina. The 26 athletes ingested a time 
release capsule which contained 167 mg of ferrous sulfate (33.4 
mg of elemental iron) daily for five to nine weeks. No 
significant differences were found in hemoglobin, hematocrit, 
serum iron or % saturation of transferrin. 
One of the first studies to show a significant increase in 
hemoglobin by dietary supplentation was done by Plowman and 
McSwegin (1981). In the study, eleven female cross country 
runners received a daily combination supplement of 1170 mg of 
ferrous sulfate (234 mg of elemental iron) and 450 mg of ascorbic 
acid for a minimum of 12 weeks. A significant increase in 
hemoglobin values pre and post supplementation was found. 
According to Plowman and McSwegin (1981) there are several 
reasons which might explain why the results of their study 
differed from the previous ones. First, the amount of elemental 
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iron ingested in their study was considerably higher. Second, to 
insure maximal absorption the iron supplement was given along 
with Vitamin C which has been shown to increase the 
bioavailability of dietary iron. Third, a tablet form rather 
than a time release capsule was utilized. The tablet form may be 
a more efficient way to provide for iron absorption. Finally, 
Plowman and McSwegin (1981) controlled the sampling of blood in 
relation to the menstrual cycle. Zilva and Patson (1966) noted 
that serum iron was significantly reduced between the two days 
immediately prior to and the first 3 days of menstrual blood flow 
in contrast to the rest of cycle. Plowman and McSwegin (1981) 
avoided taking blood samples immediately prior to and during the 
days of menstrual blood flow thereby controlling for such 
variation in serum iron. 
Valberg (1980) noted that oral iron treatment needs to be 
continued for 2 months to replenish iron stores after the 
hemoglobin concentration has reached normal values. It seems 
that hemoglobin is the first to be affected by an enhanced supply 
of iron. The body uses the increased supply of absorbed iron in 
the manufacture of hemoglobin before replenishing the storage 
forms (Plowman & McSwegin, 1981). An enhanced level of serum 
iron would occur next followed by the replenishment of storage 
iron (Plowman & McSwegin, 1981). 
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In a study by Newhouse, Clement, Taunton & McKenzie (1989) 
ferritin levels increased in one subject from 7 to 12 iig/h over 8 
weeks, while a different similarily iron-treated subject 
responded with an increase of 18 to 83 /xg/L. Newhouse et al. 
(1989) speculated that differences in absorption caused such 
variability, however the reason for the large absorption 
differences remains a question. 
It appears that some iron deficient individuals do not 
respond to iron supplementation (Newhouse, 1989). The reason for 
such nonresponse is speculative but may involve malabsorption due 
to strenuous activity, other components of the diet, pathological 
conditions, and/or prior trace mineral status (Newhouse, 1989). 
Although a few recent studies involving iron supplementation were 
successful in improving the iron status of the majority of their 
subjects each study noted cases of nonresponse (Charoenlarp et 




One hundred and eleven healthy females between the ages of 
18 and 40 from the vicinity of Thunder Bay formed the population 
from which a sample was drawn. The risks of the study were 
described and the subjects signed informed consent forms 
(Appendix A). All procedures were approved by the Lakehead 
University Ethics Committee. The subjects were permitted to 
withdraw at any time during the study. 
Forty-four subjects were iron deficient as defined by either 
a serum ferritin value below 20 /ig/L and/or a hemoglobin level 
below 120 g/L. Twenty-four of the subjects were able to complete 
the entire 24 week study and the physical characterisitics of the 
subjects are shown in Table 1. The reason for drop outs was 






























































































































Criteria for exclusion from the study were as follows; 
a) occult blood loss in the stool as determined from serial fecal 
specimen analysis during week one of the preliminary study 
(Hemocult, Smith-Kline Diagnostics, Inc.), 
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b) blood loss in the urine as determined by color changes on a 
dip-and-read Chemstrip during week one of the preliminary 
study (Chemstrip, Boehringer Mannheim Canada Ltd.)# 
c) failure to take 75% of the prescribed supplements (checked by 
pill counts at 6 week intervals), 
d) repeated ingestion of acetylsalicylic acid (aspirin) or 
medications which may cause acute or chronic blood loss from 
the gastrointestinal tract one week prior to the baseline test 
or during the 12 week supplementation programme or 12 week 
discontinuation period, 
e) pregnancy, blood donation or loss of more than 250 mL of blood 
through injury within one month of the baseline test or during 
the supplementation or discontinuation period, 
f) and finally, a fever within 2 weeks of any of the blood tests. 
Hematological data 
Blood analysis occured at 0 (TQ) , 6 (T^) , 12 (T2) , 18 (Tj) 
and 24 (T^) weeks of the study. Subjects reported to the 
physiology lab at the Lakehead University Fieldhouse in the 
morning having avoided physical activity in the preceding 24 
hours. The sampling of blood was scheduled to avoid the onset 
and duration of menstruation. No supplements, food or beverage 
were ingested by the subjects in the morning prior to the drawing 
of blood. Blood was drawn between 8:00 and 11:30 am, and each 
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subject reported at approximately the same time for each 
consecutive blood test to control for diurnal variation. 
Phlebotomy was conducted by a qualified technician familiar 
with the drawing, storing and analysis of blood. Twenty-three 
milliliters of blood was collected in Vacutainer tubes by 
antecubital venipuncture technique from each subject during each 
of the five blood tests. Samples for hemoglobin assays were 
collected in 3 mL tubes containing the anticoagulant 
ethylenediaminetetraacetic acid (EDTA). Blood for serum ferritin 
and serum iron were collected in 5 mL tubes containing a clot 
activator and serum separator and centrifuged at 3000 revolutions 
per minute (RPM) for 10 minutes. Each sample was drawn from the 
cubital vein while the women were prone. 
Blood assays were performed at the Port Arthur General 
Hospital in Thunder Bay, Ontario. Serum ferritin concentrations 
were determined by the two-site Quantimune Ferritin 
Immunoradiometric Assay (Bio-Rad Laboratories, Mississauga, 
Ontario). Serum iron was measured using Kodak Ektachem Clinical 
Chemistry Slides (Eastman Kodak Company, Rochester, New York). 
Hemoglobin assays were performed on the Coulter Counter 
instrument (Coulter Electronics, Hialeah, Florida). 
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Experimental design 
Forty-four of the original 111 subjects were iron deficient 
and were prescribed a normal therapeutic iron dose (320 mg 
ferrous sulfate or 100 mg elemental iron) taken as two SLOW-Fe 
tablets/day, in the morning and evening, for 12 weeks. Serving 
as their own controls, the subjects then discontinued iron 
supplementation for an additional 12 weeks. The response of 
serum ferritin, serum iron and hemoglobin was monitored with 
blood analysis at 6 week intervals. Twenty-four subjects 
completed the full 24 week treatment and these subjects formed 
the pool for statistical analysis. 
Training, use of concomitant and study medication, and the 
magnitude of menstrual blood loss was monitored in a log book 
(Appendix B) by each of the subjects for the duration of the 
study. No fitness or regular training criteria were imposed on 
the subjects, however, each subject was asked to record the type, 
duration (volume) and intensity of each training session. 
Training volumes for TQ, and T^ were determined by averaging 
the weekly training volumes preceding these blood collection 
dates. The magnitude of menstrual blood loss was based on two 
measurements; (a) duration of menses (# of days), and (b) percent 
saturation of each tampon/pad used per cycle. The percent 
saturation of tampon/pads was a subjective measurement made by 
each subject. Prior to the collection of menstrual data, each 
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subject was instructed on the estimation of tampon/pad 
saturation. For example, a completely saturated tampon/pad would 
represent 100 % saturation, whereas a tampon/pad that was only 
spotted might represent 10% saturation. Subjects were asked to 
record percent saturation as a fraction (e.g., 10% = 0.10). The 
percent saturations of each tampon were summed to obtain a value 
which reflected volume of blood loss per cycle (e.g., .75 + 1.00 
+ .60 + ,50 = 2.85V. No units were applied to this measurement 
since it was not an objective measurement of volume. The 
magnitude of menstrual blood loss was determined for T^, Tj, and 
T^ and was calculated using data from the menstrual period which 
preceded each of the three blood collection dates. As well, diet 
was not controlled but subjects were asked to record food intake 
for a 3 day period (2 week days and 1 weekend day) at week 0 and 
week 24. A3 day dietary analysis (Appendix C) using Moseby Diet 
Simple (N-Squared Computing, Salem, Oregon) helped to monitor the 
consistency of each subjects diet. Subjects were instructed to 
keep training and diet consistent throughout the study. Record 
of any dietary or training inconsistency will be used in the 
discussion to shed light on the pattern of results. 
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Table 2 
Schedule of Events 
Event Base Iron No 
line Supplementation Supplementation 
(TQ) (T,) (T2) (T3) (TJ 
Patient consent 




















Design of the Study 
Base Iron 
line Supplementation 























A 1 X 5 (treatment x time) analysis of variance with 
repeated measures on the second factor was utilized for each of 
the dependent measures. The independent variable was iron 
supplementation. The dependent variables were levels of serum 
ferritin, serum iron and hemoglobin. Student-Newman-Keuls post 
hoc test was used to identify specific mean differences when a 
significant F ratio was observed for the dependent measures. 
Change scores (i.e., T2 value - Tp value; T^ value - T2 value) for 
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each dependent variable, days of menses, percent saturation of 
tampon, and iron intakes were calculated. Pearson correlation 
coefficients were computed for serum ferritin versus days of 
menses, percent saturation of tampons, and iron intakes. Two- 
tailed significance levels were used for all correlations and the 
level of significance for all tests was set at p<.05. All data 




Prevalence of Iron Deficiency 
One hundred and eleven women (age 18-40 yr) underwent blood 
testing to select a sample population who fulfilled the criteria 
of iron deficiency. The results are presented in Table 4. 
Table 4 
Mean Iron Values of Normal vs. Iron Deficient Subjects at Initial 
Screening fTg) 
Group N Serum ferritin Serum iron Hemoglobin 
(Mg/L) (^mol/L) (g/L) 
Normal * 67 37.1+17.8 19.1 ± 7.5 138.8 ± 7.3 
Iron deficient ** 44 11.3 ± 5.8 14.6 ± 6.4 135.2 ± 10.0 
* Serum ferritin > 20 /xg/L and hemoglobin > 120 g/L. 
** Serum ferritin < 20 )ug/L and/or hemoglobin < 120 g/L. 
The frequency distributions of serum ferritin levels for the 
original 111 subjects are displayed in Figure 1. The mean serum 
ferritin value was 27.9 ± 21.0 jug/L. Forty three (38.7%) of the 
111 subjects had serum ferritin levels of 20 /Ltg/L or less, while 
16 subjects (14.4%) had serum ferritin levels below 10 )iig/L, 
indicating extremely depleted iron stores. 
The frequency distributions of hemoglobin levels for the 
original 111 subjects is displayed in Figure 2. The mean 
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hemoglobin value was 137.4 ±8.6 g/L. Two subjects had both low 
serum ferritin (less than 20 fig/L) and low hemoglobin (less than 
120 g/L) while two other subjects had low hemoglobin with normal 
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Figure 1. Distribution of serum ferritin levels for the subjects initially screened 
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Figure 2. Distribution of hemoglobin levels for the subjects initially screened 
for inclusion in the study. 
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On the basis of ferritin and hemoglobin measurements, 44 
women qualified to continue with the study. Twenty four of the 
selected women completed the 24 week study. The frequency 
distribution of serum ferritin levels-and hemoglobin levels at T^ 
for the 24 subjects who completed the study are displayed in 
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Figure 3. Distribution of serum ferritin levels at week 0 for the subjects who 
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Figure 4. Distribution of hemoglobin levels at week 0 for the subjects who completed the study. 
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For the 24 women who completed the study only one subject 
(4.2%) was considered anemic (hemoglobin below 120 g/L) at TQ. 
As well, 9 subjects (37.5%) had serum ferritin levels below 10 
/ug/L at TQ, indicating severely depleted iron stores. 
Effect of Iron Supplementation and Discontinuation 
The effects of oral iron supplementation and subsequent 
discontinuation on each hematological variable for the 24 
subjects are presented in Table 5. Significant changes were 
noted for serum ferritin and serum iron values while hemoglobin 
values were not significantly (p<.05) altered during the 24 week 
period. 
Table 5 
Changes in Mean Hematological Values following Supplementation 
and Discontinuation Periods 
Variable N T, 
baseIine 
•1 -^2 -^3 -^4 
supplementation discontinuation 
F Ratio 
S. Ferritin 24 x 11.5 26.4 30.6 29.0 28.2 13.84 * 
(^g/L) SD 5.3 14.3 14.9 15.0 17.1 
S. Iron 24 X 15.9 25.4 24.3 21.9 17.9 3.87 * 
(^mol/L) SD 6.7 15.6 15.4 9.8 8.3 
Hemoglobin 24 x 136.0 137.9 137.5 135.0 134.2 1.70 
(g/L) SD 8.9 9.6 9.3 7.0 6.9 
* statistically significant (p< .05). S: Serum. 
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The Student-Newroah-Keuls post hoc test was used to determine 
pairs of measurements that were significantly different (p<.05) 
for serum ferritin and serum iron (Figures 5 & 6). Seriun 
ferritin levels were significantly (p<.05) increased (11.5 to 
30.6 /ig/L) following twelve weeks of iron supplementation. A 
significant (p<.05) increase (11.5 to 26.38 ng/L) was also noted 
after six weeks of iron supplementation. Twelve weeks of 
discontinued supplementation did not significantly (p>.05) alter 
serum ferritin levels, as noted by mean values of 29.0 ± 15.0 
iug/L and 28.2 ± 17.1 /xg/L for Tj and T^, respectively. 
Figure 5. Mean serum ferritin levels at 0, 6,12, 18 and 24 weeks of the study. 
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Figure 6. Mean serum iron levels at 0, 6, 12, 18 and 24 weeks of the study. 
(* Significantly (p<.05) different from week 0). 
Serum iron levels were significantly (p<.05) increased (15.9 
to 25.4 /.tmol/L) following six weeks of iron supplementation. 
However, serum iron levels at T2, Tj and were not significantly 
different (p>.05) from the Tp or values (Figure 6). It is 
interesting, however, to note the gradual decrease in serum iron 
levels after week 6 (T.,) of the study. 
Mean hemoglobin levels for weeks 0 through 24 are presented 
in Figure 7. Hemoglobin levels remained fairly consistent and 
showed no significant (p>.05) changes for the duration of the 
study. However, there was a slight increase in levels at week 6 
followed by a gradual decrease in hemoglobin levels towards week 
24. 
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Figure 7. Mean hemoglobin levels at 0,6,12,18 and 24 weeks of the study. 
( * Significantly (p<05) different from week 0). 
Change scores for each dependent variable were standardized 
(Figure 8) by dividing mean change by the average standard 
deviation of change. This is an effect size measurement which 
permits valid comparisons between the dependent variables. 
(Glass, McGaw, and Smith, 1981). The largest positive change 
after supplementation was found for serum ferritin levels, while 
serum iron and hemoglobin levels showed smaller positive changes. 
Subsequent discontinuation resulted in small negative changes in 
serum ferritin, with comparatively larger negative changes in 
serum iron and hemoglobin levels. The change in hemoglobin 















Figure 8. Supplementation vs. Discontinuation summary. (Standard change score = mean 
change score divided by standard deviation of change). 
Mean training volumes, iron intakes, duration of menses 
(DOM) and percent saturation of tampon/pads (PST) for weeks 0, 12 
and 24 are displayed in Table 6. 
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Table 6 
Mean Training Volumes. Iron Intakes. DOM, and PST for Weeks 0. 
12 and 24. 
Variable TQ T2 
Training volume (hrs/wJc) 5.0±2.1 4.311.8 4.412.2 
(n=16) 
Iron intake (mg/day) 
(n=12) 




15.2 1 5.9 
4.8 1 1.6 
9.9 1 6.7 
4.4 1 1.3 
8.0 1 5.7 
12.8 1 3.3 
4.5 1 0.8 
8.2 1 5.2 
* No data collected. DOM: Duration of Menses. PST: Percent 
Saturation of tampons/pads. 
Training was monitored by record of type, duration and 
intensity of exercise. The subjects were all active and 
participated in activities ranging from Varsity athletics (e.g., 
basketball, volleyball and track & field), jogging, swimming, 
cross-country skiing, to weight lifting. Mean training volumes 
remained consistent for the duration of the study ranging from 
4.3 1 1.8 to 5.0 1 2.1 hours/week. Mean values for training 
intensities were not obtained due to poor compliance with filling 
out training logs. However, the majority of the subjects trained 
regularly at three quarters maximal effort. 
Mean daily iron intakes for the subjects was 15.2 ± 5.9 
mg/day at Tp (n=19) and 12.8 ± 3.3 mg/day at T^ (n=l2) . 
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The magnitude of menstrual blood loss was estimated by 
duration of menses and percent saturation of tampons. Mean 
durations of menses for TQ, T2, and were 4.9 + 1.4, 4.8 ± 1.8, 
and 4.7 ± 0.9 days. Percent saturation of tampons for TQ, T2, 
and were 9.3 ± 6.0, 9.9 ± 9.8, and 9.7 ± 6.7, respectively. 
Correlations were computed for serum ferritin versus days of 
menses, percent saturation of tampons, and iron intake at TQ. 
Correlations using change scores were also computed for serum 
ferritin versus DOM, PST and iron intake. Correlations are 
presented in Table 7. 
Table 7 
Correlations for Serum Ferritin versus Days of Menses fPOM^. 
Percent Saturation of Tampons fPST). and Iron Intakes 
Correlations 
Serum ferritin with iron intake 
II II 
II II 
" DOM (Tg) 
II PST (TQ) 
Change Scores 
S. ferritin with iron intake (T^ 
II II II DOM (T2 - TQ) 
II II II DOM (T^ - T2) 
II II II PST (T2 - TQ) 
II II II PST (T, - T,) 
n r 
(TQ) 19 .30 
20 .41 
18 .51 















A significant (p<.05) positive correlation was found between 
serum ferritin and percent saturation of tampons at Tg. This 
would suggest that subjects who had high serum ferritin levels at 
Tg also tended to have higher volumes of menstrual blood loss at 




Prevalence of Iron Deficiency 
The mean serum ferritin from the 111 women involved in the 
initial screening was 27.9 ± 21.0 M9/L- Similar results were 
noted by Valberg, Sorbie, Ludwig, and Pelletier (1976) and Cook, 
Finch and Smith (1976) who found mean serum ferritin levels of 23 
jug/L in 95 Canadian and 25 )ug/L in 370 American menstruating 
women, respectively. Although such values fall within the 
reference levels (i.e., 18-300 p.q/'L) for menstruating women, they 
should be considered as 'common' values and not 'normal' values. 
As noted by Hercberg et al. (1985, p. 236), "values observed in 
most studies concern groups of 'all-comers' women, whose 
characteristic is to be, by definition, a population at risk, 
with an important proportion of iron deficient women." 
Early studies by Scott and Pritchard (1967) and Monsen, 
Kuhn, and Finch (1967) which evaluated the iron status of healthy 
menstruating women, using bone marrow techniques for determining 
iron storage, found that more than 25% of the subjects in their 
studies were iron deficient. More recent studies have found an 
equal or even greater prevalency of iron deficiency in 
menstruating women. After screening 155 women (age 18-40), 
Newhouse et al. (1989) found that 61 of the subjects (40%) were 
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iron deficient (serum ferritin < 20 Mg/L). This compares to the 
finding in the present study where,38.7% of the subjects were 
considered to be iron deficient (serum ferritin < 20 ixg/h). 
Bothwell et al. (1979) noted that the high prevalency of 
iron deficiency in menstruating women is largely a function of 
the limited availability of iron in the contemporary diet. In 
the present study iron intakes of the subjects averaged 15.2 ± 
5.9 mg/day at Tp and 12.8 ± 3.3 mg/day at (n=12) . 
Approximately 55% of the women had mean daily iron intakes below 
the Canadian recommended intake of 14 mg/day (Health and Welfare 
Canada, 1983). A study by Newhouse et al. (1989) which examined 
the effects of prelatent/latent iron deficiency on physical work 
capacity found that approximately 80% of the subjects had mean 
dietary iron intakes below the recommended daily allowance. The 
Nutrition Canada survey (1975) also indicated inadequate mean 
iron intakes of 11.1 mg/day for the females in the 20 - 39 age 
category (Health and Welfare Canada, 1975). These results 
reinforce the common finding that it is difficult for the typical 
Western diet to meet the iron demands of the menstruating women 
(Soustre, Dop, Galan, & Hercberg, 1986). 
The mean serum iron level of the 111 women who were 
initially screened was 17.3 urtiol/l,. This compares to the studies 
by Hercberg et al. (1985) and Soustre et al. (1986) who found 
mean serum iron levels in menstruating women of 18.4 ± 7.9 /xmol/L 
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and 19.9 ± 0.5 jumol/L, respectively. The normal range for serum 
iron levels is defined as 11 - 29 jumol/L. Of the initially 
screened subjects, 21.6% (24 of 111) had below normal serum iron 
levels. Other studies (De Wijn et al., 1971; Strauzenberg et 
al., 1981) have reported similar findings. De Wijn et al. (1971) 
reported serum iron levels of less than 12.5 jumol/L in 22.5% of 
the female Olympic athletes in their study. Strauzenberg et al. 
(1981) examined 1,416 female athletes and found that 20% of the 
women had reduced serum iron levels (less than 11 /xmol/L). It 
should be noted that serum iron levels should be interpreted with 
a certain reserve due to the fact that diurnal and day-to-day 
variations of the serum iron measurement are relatively large and 
may reach 5 jumol/L (Strauzenberg et al., 1981). 
From the 111 women initially screened, it was found that the 
mean hemoglobin level was 137.4 ± 8.6 g/L. The normal range is 
defined as 120 to 160 g/L. Similar results were noted by 
Newhouse et al. (1989) and Hercberg et al. (1985) who found mean 
hemoglobin levels of 130.0 g/L in 155 Canadian women and 134,0 
g/L in 107 French women, respectively. Although the present 
research found a high prevalency of iron deficiency in its 
population group, the population was comparable to a non-anemic 
one for the distribution of hemoglobin. Only 4 subjects (3.6%) 
had hemoglobin levels below 120 g/L. Soustre et al. (1986), who 
examined 203 healthy menstruating women, found that 2.9% of the 
women had hemoglobin levels below 120 g/L. 
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Effect of iron supplementation 
Iron supplementation improved the iron levels of all 
subjects in the study. However, 7 subjects (29.2%) had ferritin 
levels less than or equal to 20 /xg/L after 12 weeks of 
supplementation. Of the 7 subjects, 5 had ferritin levels less 
than 5 ng/l> at baseline. Therefore, 12 weeks of oral iron 
supplementation was not sufficient in elevating iron stores to 
normal levels in severly iron depleted subjects within the 
present study. As well, it is interesting to note the large 
standard deviation of mean serum ferritin levels following 
supplementation in both Newhouse et al's (1989) study (37.7 ± 
19.7 Mg/b) and the present study (30.6 ± 14.9 /xg/L). One 
individual in this study increased their ferritin from 4.3 to 
11.5 jxg/L while another similarily iron treated subject responded 
with an increase from 6.7 to 47.0 /xg/L at T^. Therefore, there 
appears to be a high degree of variability in how subjects 
respond to iron therapy. Differences in absorption are likely 
the largest contributing factor to this variability. According 
to Jacobs (1985), the absorptive mechanism, whereby the amount of 
iron crossing the small intestinal epithelial barrier is related 
to internal iron status, may be defective in some people. Such 
variability in absorption may be due to genetics and/or 
interrelationships that iron has with other nutrients. 
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Among other factors known to influence iron stores, 
magnitude of menstrual blood loss and daily iron intakes seem to 
be of particularly importance (Soustre et al., 1986). Of 
interest then, would be whether changes in serum ferritin were 
correlated to changes in DOM, PST, or iron intake during the 
study. None of the three correlations were significant (r .41, 
p>.07) in the present study (Table 7). A low correlation 
suggests that only a small portion of the variance in one 
variable is predictable from the variance in the other. 
Therefore, the changes in DOM, PST, and iron intake values do not 
aid in the prediction of changes in serum ferritin values in this 
study. Such a lack of correlation was expected since DOM, PST 
and iron intakes remained fairly consistent throughout the study. 
Pearson correlation coefficients were also calculated to 
determine if baseline values of serum ferritin were correlated to 
baseline DOM, PST or iron intake values (Table 7). Percent 
saturation of tampons showed a significant positive correlation 
(r =.51, p<.05) with serum ferritin. All other correlations were 
non-significant (p>.05). Considering that both DOM and PST are 
reflections of the magnitude of menstrual blood loss, the 
positive correlation found in this study contradicts the negative 
correlation found in Soustre et al.'s (1986) study. Soustre et 
al.'s (1986) study examined 127 women and found that serum 
ferritin was negatively correlated with duration of menses (r = - 
0.23, p = 0.01). Simple explanations for this contradiction may 
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be related to the smaller n used in the present study and the 
fact that DOM and PST may have been poor indicators of the 
magnitude of menstrual blood loss in the present study. 
The finding that serum ferritin and daily iron intake were 
not correlated supports the findings of Soustre et al.'s (1986) 
study. Only a few studies have noted a relationship between diet 
and iron status. According to Soustre et al. (1986) this is 
probably due to the difficulty of evaluating dietary intakes over 
a relevant period of time since the iron status of an individual 
is probably a resultant of intakes (and losses) of iron in the 
preceeding weeks or months. According to Hallberg (1983), the 
absorption of iron from the diet is determined more by meal 
composition than by the amount of iron present in the diet. 
Therefore, classification of food items into those which enhance 
and those which inhibit iron absorption may have been more 
appropriate for determining the relationship between diet and 
iron status. 
The present study found no significant (p>.05) change in 
hemoglobin levels (136.0 ± 8.9 to 137.5 ± 9.3 g/L) during the 
supplementation period. Similar results were found by Newhouse 
et al. (1989) and Pate et al. (1979) who found that oral iron 
supplements administered to non-anemic women athletes, had no 
statistically significant impact on hemoglobin levels. According 
to Plowman and McSwegin (1981) this result is to be expected 
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since only under anemic circumstances does the body normally use 
the increased supply of absorbed iron in the manufacture of 
hemoglobin before replenishing the storage forms of iron. 
Newhouse and Clement (1988) concluded that the major determinant 
of a hemoglobin response is likely to be the initial degree of 
iron deficiency. 
Effect of supplement discontinuation 
Mean serum ferritin levels were not significantly decreased 
after six (30.6 to 29.0 tJ.q/'L) or twelve weeks (29.0 to 28.2 jug/L) 
of discontinued supplementation. These results contradict the 
findings of Hercberg et al.'s (1985) study where ferritin levels 
were significantly decreased from 46.4 ± 30.3 to 40.6 ± 23.4 jug/L 
following 30 days of discontinued supplementation. Such 
contradiction may have resulted from the different durations of 
iron treatment used in Hercberg et al.'s (1985) study compared 
with the present study (i.e., 4 and 12 weeks respectively). 
Valberg (1980) noted that oral iron supplementation needs to be 
continued for at least 2 months to replenish iron stores. It may 
be that some of the subjects in Hercberg et al.'s (1985) study 
were not sufficiently repleted prior to discontinuing 
supplementation. This may have placed the subjects in a 
vulnerable position for developing depleted iron stores during 
the one month discontinuation period. Another possible 
explanation may stem from the fact that not all of the subjects 
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were iron deficient at the beginning of Hercberg et al.'s (1985) 
study. Therefore, once treated with iron supplements these 
previously non-deficient subjects may have developed falsely 
elevated iron stores. Subsequent discontinuation of iron 
supplements may have caused the iron stores in these subjects to 
quickly return to their previous normal levels since elevated 
levels of serum ferritin were not needed. 
Although mean serum ferritin levels were not significantly 
decreased with discontinued supplementation the large standard 
deviation at (28.2 ± 17.1 ng/h) suggests that there is a great 
deal of variability in the response to discontinued iron 
supplementation. For example, one individual in this study 
showed a decrease in ferritin from 48.5 to 11.7 /:xg/L while a 
different individual had an decrease in ferritin from 47.9 to 
37.1 jug/L during the 12 week discontinuation period. This would 
suggest that certain individuals may be prone to developing iron 
deficiency following a successful iron supplementation programme. 
Although mean hemoglobin levels were not significantly 
(p>.05) decreased following 12 weeks of discontinued iron 
supplementation the values did decrease from 137.5 ± 9.3 f^g/h at 
Tj to 134.2 ± 6.9 at T^. It is also interesting to note 
that the value at T^ was less than the baseline (Tp) value of 
136.0 ± 8.9 g/L. 
CHAPTER 6 
SUMMARY/ CONCLUSIONS AND RECOMMENDATIONS 
Summary 
The primary purpose of this study was to determine the 
effects of discontinued iron supplementation on the hematological 
values of serum ferritin, serum iron and hemoglobin in a group of 
iron replete menstruating women who were previously iron 
deficient. Secondary purposes of the study included: (a) to 
establish the prevalency of iron deficiency in a group of 
menstruating women and, (b) to examine the effects of iron 
supplementation on the hematological values of serum ferritin, 
serum iron and hemoglobin in a group of iron deficient women. 
One hundred and eleven women (18-40 yr of age) were intially 
screened for iron deficiency (serum ferritin below 20 /lig/L and/or 
hemoglobin below 120 g/L). Forty four women (39.6%) qualified as 
iron deficient. Twenty four of the selected women completed the 
24 week study. Mean age was 27.6 ± 7.5 years (range 18 to 40 
years). Analysis of the data indicated that iron 
supplementation significantly (p<.05) improved serum ferritin 
levels while levels of serum iron and hemoglobin were not 
significantly increased after 12 weeks of iron supplementation. 
Subsequent discontinuation did not significantly alter serum 




Oral iron supplementation (320 mg ferrous sulfate = 100 mg 
elemental iron taken as SLOW-Fe twice a day for 12 weeks) was 
successful in raising serum ferritin levels in iron deficient 
women. 
Within the limitations of the study, 12 weeks of 
discontinued oral iron supplementation does not pose a threat to 
the iron status of iron repleted menstruating women. 
\] 
Recommendations 
1. Use of the dietary history method L'or diet analysis may 
give a better indication of the relationship between iron status 
and dietary intakes. 
2. A better indicator for the magnitude of menstrual blood 
loss is needed to accurately establish the correlation between 
menstrual blood loss and iron status. 
3. Examination of a large group of severely iron depleted 
(serum ferritin below 12 jug/L) non-anemic women is needed to 
establish this specfic group's response to discontinued oral iron 
supplementation. 
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School of Physical Education and Athletics 
Subject Consent Form 
The purpose of this study is to: 
A. examine the effects of discontinuing iron supplementation 
on the hematological values of serum ferritin, serum iron and 
hemoglobin. 
B. examine the effects of oral iron supplementation on the 
hematological values of serum ferritin, serum iron and 
hemoglobin. 
C. establish the prevalency of iron deficiency in a group 
of women. 
Subjects will be blood tested for serum ferritin, serum iron and 
hemoglobin. Those meeting the criteria for iron deficiency 
(serum ferritin below 20 /xg/L and/or hemoglobin below 120 g/L) 
will continue in the study and undergo the following tests: 
A. urinalysis: for hemocyturia (blood loss in urine) 
B. stool analysis: for occult blood loss 
C. 3-day dietary records: for nutrient intake analysis 
You will be asked to record all training, an estimate of 
menstrual blood loss, and any other factors that may influence 
testing for the duration of the study. Training and diet should 
be kept consistent with previous habits. 
Testing will be performed at 6 week intervals for a duration of 
24 weeks. The treatment will be 12 weeks of iron supplementation 
[a daily dosage of 320 mg ferrous sulfate (100 mg elemental iron) 
taken as SLOW-Fe twice a day] followed by 12 weeks of no 
supplementation. Supplementation of dietary iron will not be 
permitted for the duration of the second 12 week period. 
Side effects of iron supplementation have been reported to affect 
a small percentage of the population and these include nausea, 
constipation, and abdominal pain (Gomez & Gomez, 1969). 
Blood sampling will be conducted by qualified technicians. The 
amount of blood drawn will be small and there will be little 
discomfort with the procedure. There may be slight bruising at 
the point of puncture. Iron status may return to a deficient 
state during the 12 week discontinuation period. However, blood 
analysis will monitor for any serious drops in iron levels. 
Publication of results will not reveal subject identity as 
subjects will be referenced by number. 
I have read and understand the above explanation of the purpose 
and procedures for this study and agree to participate. I also 
understand that I have the option to withdraw from the experiment 
at any time and/or omit any part of any test. I further consent 






Exercise Diary/Menstrual Blood Loss Record 
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#3   #4  #5  #6  







Menstrual Blood Loss: 
#3  #4__  #5  
Medications 
saturation of tampon/pad #1 
#6  
 Health Complaints  
#2 
Wednesday (Date) 
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Three days of dietary intake (two weekdays and one weekend 
day) and physical activity was recorded by each subject and 
analysed using Moseby Diet Simple (N-Squared Computing, Salem, 
Oregon). The instruction sheets and diet record forms, developed 
by the YMCA (Vancouver YMCA, British Columbia, 1983) were used by 
the subjects and are shown on the following pages (pp. 69-73). 
YMCA COMPUTERIZED NUTRITIONAL ANALYSIS 
SECTION B 
INSTRUCTIONS R3R COMPLETING FOOD RECORD (You May Keep This Portion) 
1. Use a worksheet (see sample) to list 
EVERYTHING YOU ATE OR DRANK tor EACH 
DAY to be analyzed. Be sure to include: 
a) ALL R30D AND DRINKS, tor example: 
snacks, sugar and cream in coffee, 
may^naise in a sandwich, sauce on 
vegetables, candies, soft drinks, wine, etc. 
b) THE TIME OF DAY these foods were 
consumed. 
c) THE AMOUNT OF FOOD that you ate (ounces, 
slices. Clips, teaspoons, etc., in whole or 
decimal numbers). 
TIME OF DAY? HOW MUCH? FOOD OR DRINK? 
2. On the WHITE COMPUTER SHEET, enter the NUMBER OF SERVINGS of ALL foods and drinks ACCORDING TO LISTED 
SERVING SIZE 
a) Break down all combination foods. 
(For example, cheese omelette in food record above.) 
b) NOTE THE SERVING SIZE c) WRITE the number of servings you had in the 
CORRECT TIME SLOT 
FOODS EATEN Serving 
Size 
NO. OF SERVING 
5 am - 
11 am 
-t il am • f 6 pm ' 




MEAT, nSH, EGG OR POULTRY 
EGG 10129 
Cheese: Cheddar 1 oz 10009 
Vegetable Oil 1 tbsp. 40518 
SECTION C; ACnVITY RECORD 
1. Use a worksheet (see sample) to RECORD YOUR 
ACTIVITY FOR EACH DAY, (that is. tor 24 HOURS.) 
Activity levels explained below. 
2. TOTAL THE NUMBER OF HOURS SPENT AT EACH 
LEVEL. The total must EQUAL 24 hours. 
3. WRITE THE TOTAL HOURS spent at EACH LEVEL 
in the ACnviTY sectton at the top of the WHITE 
COMPUTER FORM. 
TIME OF DAY LENGTH OF TIME ACnVITY LEVEL* 
ACTTVTTY: Hours at each level 1 2.. a A  S  
Acney ftama V«y 
CHECK THAT YOU HAVE COMPLETED ALL SECTIONS OF THE GREEN PERSONAL FORM AND WHITE COMPUTER 
24.0 Hours 
69 





Sitting, eating, watching T.V. dasswork, office work, driving, playing 
quietly, playing a musical instrument sailing, STAf^ING, petsonai toilet 
teaching, laboratory work. HOUSEWORK, SHOPPING, cooking, bowlmg. 
pool 
LEVEL 3 (Count only the TIME that you are 
ACTIVELY PARTICIPATING) 
BRISK WALKING (2-3 BICYCUNG 
(5.5 farming, gardening, mechanical 
work. electricaJ trades, house-painting, restaurant 
trades, loading/stacking, carpentry, dancing, 
ba.sftfaall, weight training, golif, RE^EAHONAL 
swimming, table tennis, tennis. voiieybaJt 
canoeing or rowing 
LEVELS 4 and & Activities at these levels should cause you to raise your HEART RATE, to BREATHE HARO, to PERSPIRE, to 
use ALL YOUR EFFORT. Count only the TIME that you are ACTIVELY PARTiaPATING, 
LEVEL4 
WALKING/JOGGING (4,5-5 
hiking, BICYCLING 00 ni,pJi.}, digging, 
skipping, downhili skiing, recreational 
basketball, badminton or skating, canoeing 
(4 ntpA), competitive table tennis or 
terra 
LEVELS 
RUNNING (mors than 5 m,pJi.), 
fbotbaii, hockey, soccer. iacnKse. 
bicyding (13 iTMjit). COMPETITIVE 
badminton, volleybail or basketball, 
racquet sports, vigorous skating or —- 
rowing, cross-country skung. martiai 
arts, swimming (45 yards/mia or mote) 
'Jo 
V/ 




Day S^onih Year 
EVALUATION DAY NUMBER. 
no? 





Light Activity Active Very Active 
= 24.0 Hour 
FOODS EAIEN Serving 
Size 
NO. OF SERVINGS 
Sam ■ 
11 am 
11 am ■. 
5 pm 





FOODS EATEN Serving 
Size 










MILK AND MILK PRODUCTS FRUITS 




processed (l slice), spread (2 Ibsp.) 
Swiss or gouda 
Ice cream 
Ice milk 
Instant breakfast: with milk 
MILK: chocolate 
condensed.sweetened, canned 

























CANNED: (sweetened): applesauce 
apricots 
cherries 






















melons: cantaloupe (orange) 
honeydew (pale green) 
BREADS AND CEREALS watermelon 
BISCUITS: baking powder, scone (2”xt Vr' 
BREADS: European, dark' 
fruit bread, raisin 
white, enriched 
whole wheat, whole grain 
BUNS, ROLLS: plain, hamburger 
whole wheal 
CEREALS: cooked, whole grain 
dry. flaked, enriched 
dry. shredded, whole grain 






whole grain, bran 
RASTA: macaroni, noodles, spaghetll 
RANCAKES, WAFFLES: 4" diam. 
FIE CRUST: plain, lower crust 
RICE: brown 






















peach, nectarine ( VI), 












































FOODS EAIEN Serving 
Size 
NO. OF SERVINGS 
5 am - 
11 am 
11 am ■ 
5 pm 






FOODS EATEN Serving 
Size 
NO OF 
5 am - 
11 am 







DESSERTS. SWEETS. BAKED GOODS 
COOKED: asparagus 







Chinese greens, bok choy 






potatoes: baked, boiled, mashed 




squash: winter, yellow 
summer, zucchini 
tomatoes, baked, canned 
turnips 
RAW: salads: mayonnaise 
jellied vegetable 










sprouts: bean, ailalla 
tomato 







































Jam. jelly, honey, syrup 
Molasses 
Sugar: white, brown 
Sweet sauce, topping 




CAKE: angel tood 
Ituil 
plain, no Icing 
rich, with icing 





Doughnut. Danish pastry, eclair 
Fruit crisp 
Jellied dessert, jello 
Pie (3VI" wedge), tart, turnover 
Popstcle, ices 


























BEVERAGES OR DRINKS 
ALCOHOL: beer 
liqueut(1 oz). dessert wine(1 Vi oz| 
liquor 
wine, table 
Cazbonaled. pop (non diet) 
Collee 
FtuR llavoured drink (crystals) 
Hot chocolate (no milk) 
Lemonade 
Rostum. coflee substitutes 













Corn chips or snacks, cheezles 1 sm. pkg 




I sm. pkg 
I 
72 
•os EATEN SAiving 
•it* 
NO OF SERVINGS 
5»»n-l 11 






FOODS EATEN Serving 
Size 










IT, FISH, EDO OR POULTRY SOUPS. SAUCES, COMDIMENTS, OTHER 
T: cod, halibut, sole: baked 
deep Iried 
lish slicks 
Iresh water lish 
salmon, tuna: baked 
canned 
LLFISH: clams(5), oysters(9) 
crab, lobster 
shrimp, scallops 




deli-style meats (t slice) 
lamb: roast, chop 
liver, organ meals 
liver pile 
luncheon meat, canned 
pork: bacon (side) 
ham. hack bacon 
roast, chops (2 small] 
sausages {A" link] 
spareribs 
weiner (Irankturter) 





































S: salted, roasted 
unsalled, raw 
ul butter 













SOUPS: broth: consomme, plain 
with vegetables 
with noodles 
chowder, clam (no milk) 
cream soups, all (with milk) 
lentil, split pea 
SAUCES: gravy 
tomato 
while, (it cheese, add 'A oz Cheddar) 
Mustard 



















Baked beans with tomato sauce 
Chili with beans 
Chop suey with meat 
Macaroni and cheese 
Meal loal 
Meal pie (I small, 3'A " wedge) 
Pizza with cheese, tomato sauce 
Spaghetti with cheese, tomato sauce 










FATS. CREAMS AND OILS 




Cottae whilener. cream substitute 
Margarkie 
Vtoetable oil 
SALAD DRESSINGS: blue cheese 
french, oil and vinegar 


















Serum Ferritin Values (ua/L) for each Subject, at. 0. 6. 12. 18. 
and 24 Weeks of the Study 
Subject TQ T2 T3 
































































































































































































































Serum Iron Values fumol/L) for each Subject at 0. 6. 12. 18 and 
24 Weeks of the Study 
Subject 
# 
•^0 -^1 -^2 ^3 -^4 






























































































































































































Hemoglobin Values fg/L) for each Subject at 0. 6. 12, 18 and 
24 Weeks of t.he Study 
Subject T(j T, T2 T3 



























































































































































































































































































































































= missing value, 
77 
















































































* = missing value 
